Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

ERBB3

v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)HER3v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3


Gene ERBB3 gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Humans

1870.0

1-Phosphatidylinositol 3-Kinase/metabolism

50.0

Breast Neoplasms/metabolism

21.0

Enzyme Activation

240.0

*Gene Expression Regulation

20.0

Mitogen-Activated Protein Kinases/metabolism

60.0

Neuregulin-1/*physiology

444.0

Receptor, erbB-2/*metabolism

2214.0

Research Support, U.S. Gov't, P.H.S.

880.0

Tumor Cells, Cultured

560.0

Antibodies, Monoclonal/pharmacology

20.0

Antineoplastic Agents/*pharmacology

30.0

Cell Division/drug effects

150.0

Enzyme Inhibitors/pharmacology

100.0

Epidermal Growth Factor/*pharmacology

50.0

Growth Substances/pharmacology

21.0

*Intercellular Signaling Peptides and Proteins

40.0

Ligands

281.0

Neuregulin-1/pharmacology

746.0

Phosphorylation

460.0

*Protein-Serine-Threonine Kinases

70.0

Proto-Oncogene Proteins/metabolism

161.0

Receptor, Epidermal Growth Factor/*antagonists & inhibitors

21.0

Receptor, erbB-2/*antagonists & inhibitors

213.0

Research Support, Non-U.S. Gov't

1270.0

Cell Line

290.0

Dimerization

161.0

Receptor, Epidermal Growth Factor/*metabolism

253.0

Receptor, erbB-2/*physiology

728.0

Receptor, erbB-3/*physiology

360.0

Research Support, U.S. Gov't, Non-P.H.S.

160.0

Signal Transduction

270.0

Tyrosine/*metabolism

30.0

Adult

180.0

Female

620.0

Gene Expression

60.0

Neuroblastoma/genetics

28.0

Receptor, erbB-3/genetics

266.0

Reverse Transcriptase Polymerase Chain Reaction

130.0

Sarcoma, Ewing's/genetics

218.0

Amino Acid Sequence

360.0

Kinetics

90.0

Models, Molecular

60.0

Molecular Sequence Data

430.0

Protein Conformation

50.0

Receptor, Epidermal Growth Factor/chemistry/metabolism

228.0

Receptor, erbB-2/chemistry/metabolism

266.0

Receptor, erbB-3/chemistry/metabolism

2100.0

Immunohistochemistry/methods

71.0

Prognosis

80.0

Receptor, erbB-2/*analysis

33.0

Survival Analysis

30.0

Immunohistochemistry

110.0

Male

340.0

Middle Aged

200.0

Receptor, erbB-3/*metabolism

1257.0

Aged

170.0

Aged, 80 and over

80.0

Blotting, Western

170.0

Receptor, Epidermal Growth Factor/analysis

42.0

Receptor, erbB-3/*analysis

360.0

Animals

810.0

COS Cells

30.0

Cercopithecus aethiops

20.0

Neuregulins/*metabolism

375.0

Proteins/genetics/*metabolism

20.0

Receptor, erbB-2/metabolism

1911.0

Receptor, erbB-3/genetics/*metabolism

3100.0

Amino Acid Motifs

20.0

Binding, Competitive

20.0

Dose-Response Relationship, Drug

60.0

Gene Library

20.0

Glutathione Transferase/metabolism

30.0

Precipitin Tests

80.0

Protein Binding

160.0

Protein Structure, Tertiary

110.0

Recombinant Fusion Proteins/metabolism

40.0

Tyrosine/metabolism

151.0

src Homology Domains

40.0

*Genes, erbB

436.0

*Genes, erbB-2

44.0

Insulin/*pharmacology

20.0

MAP Kinase Signaling System

20.0

*Trans-Activation (Genetics)

20.0

Tumor Necrosis Factor-alpha/*pharmacology

20.0

*ADP Ribose Transferases

22.0

*Bacterial Toxins

21.0

Phosphotyrosine/metabolism

40.0

Receptor, Epidermal Growth Factor/metabolism

234.0

Recombinant Proteins/metabolism

40.0

Time Factors

70.0

*Virulence Factors

22.0

Antineoplastic Agents/pharmacology

30.0

Breast Neoplasms

51.0

Cell Division/physiology

20.0

MAP Kinase Signaling System/*physiology

22.0

Microscopy, Fluorescence

30.0

Phthalimides/pharmacology

2100.0

Receptor, Epidermal Growth Factor/antagonists & inhibitors/*metabolism

26.0

Receptor, erbB-2/genetics/*metabolism

412.0

Recombinant Fusion Proteins/genetics/metabolism

20.0

CHO Cells

50.0

Cell Line, Tumor

120.0

Hamsters

70.0

In Vitro

60.0

Oncogene Proteins v-erbB/metabolism

333.0

Recombinant Proteins/chemistry/genetics/metabolism

30.0

Sequence Homology, Amino Acid

160.0

Drug Screening Assays, Antitumor

20.0

Gene Expression Regulation, Neoplastic

120.0

Receptor, Epidermal Growth Factor/genetics/*metabolism

42.0

1-Phosphatidylinositol 3-Kinase/*physiology

35.0

Proto-Oncogene Proteins/*physiology

20.0

Receptors, Muscarinic/*physiology

29.0

Trans-Activation (Genetics)

20.0

Comparative Study

260.0

Neoplasm Invasiveness

50.0

Receptor, erbB-2/analysis

22.0

Cell Cycle

40.0

Cloning, Molecular

150.0

DNA, Complementary/metabolism

40.0

Drosophila

20.0

Fibroblasts/metabolism

20.0

Immunoprecipitation

20.0

Mice

370.0

NIH 3T3 Cells

20.0

Receptor, erbB-3/*chemistry

266.0

Transfection

200.0

Ubiquitin/metabolism

20.0

Signal Transduction/physiology

50.0

Tyrphostins/pharmacology

21.0

Blotting, Northern

90.0

Fluorescent Antibody Technique

40.0

Heparin/metabolism

21.0

Mice, Inbred C57BL

20.0

Mice, Knockout

20.0

Tumor Cells, Cultured/drug effects/metabolism

21.0

Oligonucleotide Array Sequence Analysis/*methods

21.0

Gene Expression Regulation, Developmental

30.0

Mammary Glands, Animal/*metabolism

210.0

Signal Transduction/*physiology

80.0

Cohort Studies

20.0

Neoplasm Staging

40.0

Receptor, erbB-2/*biosynthesis

48.0

Receptor, erbB-3/*biosynthesis

350.0

Databases, Factual

20.0

*Gene Expression Regulation, Neoplastic

30.0

Protein Isoforms

50.0

Solubility

30.0

1-Phosphatidylinositol 3-Kinase/*metabolism

51.0

Proto-Oncogene Proteins/*metabolism

111.0

*Signal Transduction

110.0

DNA, Neoplasm/*analysis

21.0

*Gene Expression Profiling

20.0

RNA, Neoplasm/genetics

20.0

Tissue Distribution

40.0

3T3 Cells

70.0

Phosphorylation/drug effects

60.0

Sequence Deletion

20.0

Epidermal Growth Factor/pharmacology

60.0

Antibodies/immunology

20.0

Carcinoma, Squamous Cell/*metabolism

21.0

Receptor, erbB-3/metabolism

1655.0

Cell Membrane/*metabolism

20.0

Cells, Cultured

170.0

RNA, Messenger/metabolism

120.0

Rats

240.0

Transcription, Genetic

60.0

Endothelium, Vascular/*cytology

21.0

Promoter Regions (Genetics)

40.0

RNA, Messenger/biosynthesis/genetics

20.0

Recombinant Proteins/pharmacology

20.0

Up-Regulation

60.0

Vascular Endothelial Growth Factor A

20.0

Vascular Endothelial Growth Factors

20.0

p38 Mitogen-Activated Protein Kinases

40.0

Receptor Protein-Tyrosine Kinases/*metabolism

41.0

Breast Neoplasms/*pathology

20.0

Down-Regulation

50.0

Estrogen Antagonists/pharmacology

22.0

Signal Transduction/drug effects

40.0

Tumor Cells, Cultured/drug effects

40.0

Receptors, Estrogen/metabolism

31.0

*Gene Expression

40.0

Genes, erbB-1

211.0

Genes, erbB-2

33.0

Receptor Protein-Tyrosine Kinases/genetics/*metabolism

21.0

Protein-Serine-Threonine Kinases/*metabolism

20.0

Adolescent

50.0

Base Sequence

180.0

DNA Primers

60.0

Receptor, erbB-2/*genetics

38.0

Central Nervous System Depressants/*pharmacology

212.0

Ethanol/*pharmacology

21.0

Receptor, Epidermal Growth Factor/biosynthesis/*metabolism

313.0

Cell Survival/drug effects

40.0

Animals, Newborn

20.0

Cell Adhesion

30.0

Cell Communication

20.0

Coculture Techniques

30.0

Models, Neurological

21.0

Rats, Sprague-Dawley

50.0

Neoplasm Proteins/*metabolism

20.0

Neuregulin-1/*metabolism

428.0

Cell Differentiation/genetics

31.0

Gene Expression Regulation, Neoplastic/*genetics

31.0

RNA, Messenger/genetics

40.0

Signal Transduction/genetics

31.0

Cell Differentiation

40.0

Cell Division

140.0

Cell Separation

20.0

Phenotype

20.0

*Alternative Splicing

20.0

Binding Sites

120.0

Cell Membrane/metabolism

20.0

Protein Isoforms/genetics/metabolism

21.0

Rabbits

30.0

Androstadienes/pharmacology

41.0

Blotting, Southern

40.0

Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism

61.0

Epidermal Growth Factor/*metabolism

41.0

Breast Neoplasms/*metabolism

51.0

Breast Neoplasms/*metabolism/pathology

21.0

Cell Count/drug effects

22.0

Culture Media, Serum-Free

20.0

Neuregulin-1/metabolism

215.0

Alternative Splicing

20.0

Oncogene Proteins v-erbB/*metabolism

233.0

RNA, Messenger/analysis

30.0

Cell Cycle/drug effects

50.0

Antibodies, Monoclonal

40.0

Fluorescent Antibody Technique, Indirect

20.0

Breast Neoplasms/metabolism/*pathology

22.0

*Cell Cycle Proteins

20.0

Mitogen-Activated Protein Kinase 1/metabolism

30.0

Mitogen-Activated Protein Kinase 3

30.0

Protein-Serine-Threonine Kinases/metabolism

20.0

Proto-Oncogene Proteins c-myc/metabolism

22.0

Receptor, erbB-2/chemistry/drug effects/*physiology

2100.0

Recombinant Proteins/chemistry/metabolism

20.0

Spodoptera

20.0

Microscopy, Confocal

20.0

Microscopy, Electron

20.0

Bladder/cytology/*metabolism/pathology

266.0

Epidermal Growth Factor/genetics/metabolism/*physiology

240.0

Mice, Inbred Strains

20.0

Mitogens/pharmacology

31.0

Muscle, Smooth/cytology/*metabolism/pathology

2100.0

Urethral Obstruction/*metabolism/pathology

2100.0

DNA/biosynthesis

30.0

Receptor, Epidermal Growth Factor/*physiology

21.0

Androgens/metabolism

23.0

Cell Division/drug effects/physiology

31.0

Epidermal Growth Factor/metabolism

51.0

Glycoproteins/*pharmacology

77.0

*Mitogen-Activated Protein Kinases

20.0

Neuregulins

1322.0

Protein-Tyrosine Kinase/metabolism

60.0

Receptor, erbB-3

3641.0

Retinoblastoma Protein/metabolism

30.0

Cytoplasm/enzymology

22.0

Sequence Analysis, DNA

20.0

*Intracellular Signaling Peptides and Proteins

40.0

Macromolecular Substances

50.0

Receptor, Epidermal Growth Factor/chemistry/*metabolism

411.0

Cell Division/genetics

20.0

*Adaptor Proteins, Signal Transducing

50.0

Proteins/metabolism

40.0

Signal Transduction/*drug effects

30.0

Proto-Oncogene Proteins/chemistry/*metabolism

23.0

*Neuregulin-1

1765.0

Reproducibility of Results

30.0

Sensitivity and Specificity

40.0

NF-kappa B/metabolism

20.0

Proteoglycans

22.0

Carrier Proteins/chemistry/*metabolism

22.0

Epithelial Cells/metabolism

20.0

Glycoproteins/chemistry/*metabolism

216.0

Cluster Analysis

21.0

Gene Expression Profiling

30.0

Genes, erbB/*genetics

266.0

Receptor, erbB-3/biosynthesis/genetics

2100.0

Immunoenzyme Techniques

50.0

Proto-Oncogene Proteins/genetics/*metabolism

20.0

Polymerase Chain Reaction

40.0

Receptor, erbB-2/biosynthesis/*genetics

228.0

Carrier Proteins/*metabolism

50.0

Glycoproteins/*metabolism

52.0

Child

20.0

Child, Preschool

20.0

RNA, Messenger/biosynthesis

50.0

Receptor, erbB-2/genetics/metabolism

320.0

Receptor, erbB-3/genetics/metabolism

375.0

Reverse Transcriptase Polymerase Chain Reaction/methods

41.0

Survival Rate

30.0

Antibodies

20.0

Carrier Proteins/*pharmacology

48.0

Protein Kinase Inhibitors

21.0

Protein Kinases/metabolism

20.0

Protein Structure, Secondary

40.0

Structure-Activity Relationship

30.0

*Adaptor Proteins, Vesicular Transport

20.0

Pregnancy

20.0

Risk Factors

20.0

*Protein Conformation

31.0

Peptide Mapping

20.0

Proteins/*metabolism

20.0

DNA-Binding Proteins/drug effects/metabolism

27.0

Enzyme Activation/drug effects

30.0

Trans-Activators/drug effects/metabolism

29.0

Transplantation, Heterologous

30.0

Enzyme Inhibitors/*pharmacology

30.0

DNA, Complementary/genetics

30.0

In Situ Hybridization

20.0

PC12 Cells

20.0

Breast/metabolism

22.0

Organ Specificity

20.0

Recombinant Fusion Proteins/biosynthesis/chemistry/metabolism

28.0

Growth Substances/*pharmacology

20.0

Recombinant Proteins/metabolism/pharmacology

21.0

Receptor, Epidermal Growth Factor/*genetics/metabolism

23.0

Genes, erbB

562.0

Sequence Alignment

50.0

1-Phosphatidylinositol 3-Kinase

74.0

Phosphotransferases (Alcohol Group Acceptor)/*metabolism

44.0

Thymidine/metabolism

30.0

Protein Folding

20.0

Mice, Transgenic

50.0

Receptor Aggregation

22.0

Recombinant Proteins/chemistry

20.0

Disease-Free Survival

20.0

Gene Expression Regulation

40.0

Protein-Tyrosine Kinase/*metabolism

20.0

Receptor, Epidermal Growth Factor/genetics/metabolism

35.0

Receptor Protein-Tyrosine Kinases/metabolism

20.0

Ovarian Neoplasms/*metabolism/pathology

23.0

Magnetic Resonance Spectroscopy

20.0

Phosphotransferases (Alcohol Group Acceptor)/metabolism

34.0

Restriction Mapping

20.0

Glycoproteins/physiology

26.0

Molecular Weight

20.0

Breast Neoplasms/*genetics

20.0

DNA Primers/chemistry

30.0

Phosphotyrosine

41.0

Tyrosine/analogs & derivatives/metabolism

32.0

Dexamethasone/pharmacology

20.0

Immunologic Techniques

20.0

Gene Expression Regulation/*physiology

20.0

Neoplasm Transplantation

20.0

Antineoplastic Agents/pharmacology/therapeutic use

26.0

*Proto-Oncogenes

20.0

Neuregulin-1/*pharmacology

317.0

RNA, Small Interfering/pharmacology

22.0

Receptor, Epidermal Growth Factor/genetics

21.0

Receptor Cross-Talk/*physiology

215.0

Gene Deletion

20.0

*Oligonucleotide Array Sequence Analysis

21.0

Receptor, Epidermal Growth Factor/*genetics

20.0

Receptors, Progesterone/metabolism

21.0

Neuregulin-1/genetics/*metabolism

2100.0

Crystallography, X-Ray

30.0

Adenocarcinoma/metabolism/pathology

23.0

Mitogen-Activated Protein Kinases/*metabolism

20.0